Cell Therapy Global Market Report 2025

Description

Cell therapy involves the replacement or repair of damaged tissue and/or cells by transplanting human cells. Various types of cells can be employed as part of a therapy or treatment for a range of diseases and disorders, leveraging new technologies, innovative products, and boundless imagination. This treatment form entails the administration of live cells to patients through injection, grafting, or implantation to achieve a therapeutic outcome.

The primary techniques employed in cell therapy include stem cell therapy, cell vaccines, adoptive cell transfer (ACT), fibroblast cell therapy, and chondrocyte cell therapy. Stem cell treatment, also recognized as regenerative medicine, utilizes stem cells or their derivatives to stimulate the healing response in diseased, defective, or injured tissues. Allogeneic therapies and autologous therapies are the two main types of therapies used in various applications such as oncology, cardiovascular disease (CVD), orthopedics, wound healing, and more.

The cell therapy market research report is one of a series of new reports from The Business Research Company that provides cell therapy market statistics, including cell therapy industry global market size, regional shares, competitors with a cell therapy market share, detailed cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy industry. This cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell therapy market size has grown rapidly in recent years. It will grow from $14.56 billion in 2024 to $17.02 billion in 2025 at a compound annual growth rate (CAGR) of 16.9%. The growth in the historic period can be attributed to early research and discoveries, regulatory milestones, clinical trials and studies, early adopters and pioneering companies, market acceptance and perception.

The cell therapy market size is expected to see rapid growth in the next few years. It will grow to $29.28 billion in 2029 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to ethical and societal considerations, investment and funding trends, consumer/patient demand, healthcare infrastructure, rapid innovation cycles. Major trends in the forecast period include personalized medicine, emerging targeted treatments, gene editing technologies, stem cell research expansion, immunotherapy advancements, microenvironment manipulation.

The increasing prevalence of chronic diseases has facilitated the growth of the cell therapy market. According to the US Centers for Disease Control and Prevention (CDC), chronic diseases are conditions that persist for a year or more, require medical attention, limit daily activities, or both, and include illnesses such as heart disease, cancer, diabetes, and Parkinson's disease. Stem cells can provide benefits to patients suffering from various conditions, including spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis. For example, in July 2024, the CDC reported significant updates regarding public health initiatives. Each year, over 944,800 Americans die from heart disease or stroke, which accounts for more than one-third of all deaths. In the U.S., 1.7 million individuals are diagnosed with cancer annually, resulting in over 600,000 deaths, making it the second leading cause of death. Additionally, more than 38 million Americans have diabetes, and another 98 million adults are prediabetic, increasing their risk of developing type 2 diabetes. Diabetes can lead to serious complications such as heart disease, kidney failure, and blindness. Furthermore, obesity affects 20% of children and 42% of adults, heightening the risk of chronic diseases like type 2 diabetes, heart disease, and certain cancers. The rising prevalence of chronic diseases has heightened the demand for cell therapies, contributing to the expansion of the cell therapy market.

Increasing investments are anticipated to drive the growth of the cell therapy market in the future. Investment in cell therapy refers to the allocation of financial resources, capital, or funding aimed at supporting the research, development, manufacturing, and commercialization of cell-based therapies. Such investments are being utilized to further research and develop new cell therapy products and technologies, as well as to conduct clinical trials evaluating these products, which will enhance and improve cell therapies. For instance, in 2023, the BioIndustry Association (BIA), a UK-based organization representing the life sciences and biotech industry, reported that UK cell and gene therapy companies secured over 55% of the venture capital funding obtained by European firms. The UK generally accounts for around one-third of all European venture capital investments in life sciences, underscoring the strength of its cell and gene therapy sector. In contrast, US companies captured 86% of the venture funding for cell and gene therapies in 2022 and are expected to outpace their international counterparts in 2023. Thus, rising investment is fueling the growth of the cell therapy market.

Key market players are strategically forming partnerships and collaborations to enhance their product portfolios and expand their geographical reach. In November 2023, Ajinomoto Co Inc., a Japan-based food company, acquired Forge Biologics for $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.'s global capabilities in AAV and plasmid gene therapy manufacturing, thereby enriching and reinforcing its existing contract development and manufacturing services. Forge Biologics is a US-based biotechnology company dedicated to advancing cell therapy technologies for various diseases.

Leading companies in the cell therapy market are pursuing strategic partnerships to deliver innovative and effective therapies to patients. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For instance, in September 2022, Genentech Inc., a US biotechnology corporation, entered into a partnership with Arsenal Biosciences, Inc., a US-based programmable cell therapy company. This collaboration aims to expedite the development of next-generation cell therapy products, potentially leading to new and more effective therapies for solid tumors-a significant breakthrough for cancer patients. Both companies are committed to investing in new technologies and delivering innovative treatments to those affected by cancer.

In August 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Sigilon Therapeutics for $34.6 million. This acquisition aims to bolster Lilly's research and development efforts in encapsulated cell therapies, specifically focusing on Type 1 diabetes with its lead candidate, SIG-002. This strategic move will enhance Lilly's position in the diabetes treatment market. Sigilon Therapeutics is a US-based biotechnology company concentrating on the development of innovative cell therapies.

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell therapy market includes revenues earned by entities by enhancing the growth of new healthy skin tissue and enhancing collagen production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Technique: Stem Cell Therapy; Cell Vaccine; Adoptive Cell Transfer (ACT); Fibroblast Cell Therapy; Chondrocyte Cell Therapy
2) By Therapy Type: Allogeneic Therapies; Autologous Therapies
3) By Application: Oncology; Cardiovascular Disease (CVD); Orthopedic; Wound Healing; Other Applications
Subsegments:
1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation; Mesenchymal Stem Cell Therapy; Embryonic Stem Cell Therapy; Induced Pluripotent Stem Cell Therapy
2) By Cell Vaccine: Dendritic Cell Vaccine; Tumor-Infiltrating Lymphocyte (TIL) Vaccine; Antigen-Specific Cell Vaccine
3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy; T-Cell Receptor (TCR) Therapy; Natural Killer (NK) Cell Therapy
4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy; Adipose-Derived Stem Cell Therapy
5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI); Chondral Graft Therapy
Companies Mentioned: Celgene Corporation; JCR Pharmaceuticals Co. Ltd.; Baxter Healthcare Corporation; Nipro Corp.; Stempeutics Research Pvt. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r26224

1. Executive Summary

2. Cell Therapy Market Characteristics

3. Cell Therapy Market Trends And Strategies

4. Cell Therapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cell Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cell Therapy Market Growth Rate Analysis
5.4. Global Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cell Therapy Total Addressable Market (TAM)

6. Cell Therapy Market Segmentation

6.1. Global Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stem Cell Therapy
Cell Vaccine
Adoptive Cell Transfer (ACT)
Fibroblast Cell Therapy
Chondrocyte Cell Therapy
6.2. Global Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allogeneic Therapies
Autologous Therapies
6.3. Global Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Other Applications
6.4. Global Cell Therapy Market, Sub-Segmentation Of Stem Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell Transplantation
Mesenchymal Stem Cell Therapy
Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
6.5. Global Cell Therapy Market, Sub-Segmentation Of Cell Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dendritic Cell Vaccine
Tumor-Infiltrating Lymphocyte (TIL) Vaccine
Antigen-Specific Cell Vaccine
6.6. Global Cell Therapy Market, Sub-Segmentation Of Adoptive Cell Transfer (ACT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CAR T-Cell Therapy
T-Cell Receptor (TCR) Therapy
Natural Killer (NK) Cell Therapy
6.7. Global Cell Therapy Market, Sub-Segmentation Of Fibroblast Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dermal Fibroblast Therapy
Adipose-Derived Stem Cell Therapy
6.8. Global Cell Therapy Market, Sub-Segmentation Of Chondrocyte Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Chondrocyte Implantation (ACI)
Chondral Graft Therapy

7. Cell Therapy Market Regional And Country Analysis

7.1. Global Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Therapy Market

8.1. Asia-Pacific Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Therapy Market

9.1. China Cell Therapy Market Overview
9.2. China Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Therapy Market

10.1. India Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Therapy Market

11.1. Japan Cell Therapy Market Overview
11.2. Japan Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Therapy Market

12.1. Australia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Therapy Market

13.1. Indonesia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Therapy Market

14.1. South Korea Cell Therapy Market Overview
14.2. South Korea Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Therapy Market

15.1. Western Europe Cell Therapy Market Overview
15.2. Western Europe Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Therapy Market

16.1. UK Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Therapy Market

17.1. Germany Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Therapy Market

18.1. France Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Therapy Market

19.1. Italy Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Therapy Market

20.1. Spain Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Therapy Market

21.1. Eastern Europe Cell Therapy Market Overview
21.2. Eastern Europe Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Therapy Market

22.1. Russia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Therapy Market

23.1. North America Cell Therapy Market Overview
23.2. North America Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Therapy Market

24.1. USA Cell Therapy Market Overview
24.2. USA Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Therapy Market

25.1. Canada Cell Therapy Market Overview
25.2. Canada Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Therapy Market

26.1. South America Cell Therapy Market Overview
26.2. South America Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Therapy Market

27.1. Brazil Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Therapy Market

28.1. Middle East Cell Therapy Market Overview
28.2. Middle East Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Therapy Market

29.1. Africa Cell Therapy Market Overview
29.2. Africa Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Therapy Market Competitive Landscape And Company Profiles

30.1. Cell Therapy Market Competitive Landscape
30.2. Cell Therapy Market Company Profiles
- 30.2.1. Celgene Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. JCR Pharmaceuticals Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Baxter Healthcare Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Nipro Corp. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Stempeutics Research Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Cell Therapy Market Other Major And Innovative Companies

31.1. Osiris Therapeutics Inc.
31.2. Vericel Corporation
31.3. AlloSource
31.4. Anterogen Co. Ltd.
31.5. Arteriocyte Medical Systems Inc.
31.6. MediPost Co. Ltd.
31.7. Pharmicell Co. Ltd.
31.8. Corestem Inc.
31.9. Stemedica Cell Technologies Inc.
31.10. Adaptimmune Therapeutics plc
31.11. Mesoblast Ltd.
31.12. Cell Medica Ltd.
31.13. Cellerant Therapeutics Inc.
31.14. Kolon TissueGene Inc.
31.15. Tego Science Inc.

32. Global Cell Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Therapy Market

34. Recent Developments In The Cell Therapy Market

35. Cell Therapy Market High Potential Countries, Segments and Strategies

35.1 Cell Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Cell Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Cell Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer